Literature DB >> 16603093

Deletions in the Y-derived amelogenin gene fragment in the Indian population.

V K Kashyap1, Sanghamitra Sahoo, T Sitalaximi, R Trivedi.   

Abstract

BACKGROUND: Rare failures in amelogenin-based gender typing of individuals have been observed globally. In this study, we report the deletion of a large fragment of the amelogenin gene in 10 individuals out of 4,257 male samples analyzed from 104 different endogamous populations of India.
METHODS: Samples were analyzed using commercial genetic profiling kits. Those that exhibited failures in amelogenin-based gender identification were further analyzed with published as well as newly designed primers to ascertain the nature and extent of mutation.
RESULTS: The failure rate among Indian males was 0.23 %. Though the exact size and nature of the deletion (single point mutations at a number of positions or a single large deletion) could not be determined in the present study, it is inferred that the deletion spans a region downstream of the reverse primer-binding site of commercially available amelogenin primer sets. Deletions were conspicuously absent among the Mongoloid tribes of Northeast India, while both caste and tribal groups harbored these mutations, which was predominantly among the Y-chromosomes belonging to J2 lineage.
CONCLUSION: Our study indicates that the different amelogenin primer sets currently included in genetic profiling multiplex kits may result in erroneous interpretations due to mutations undetectable during routine testing. Further there are indications that these mutations could possibly be lineage-specific, inherited deletions.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16603093      PMCID: PMC1458324          DOI: 10.1186/1471-2350-7-37

Source DB:  PubMed          Journal:  BMC Med Genet        ISSN: 1471-2350            Impact factor:   2.103


Background

Genotyping the X-Y homologous amelogenin gene segment for gender identification is widely used for DNA profiling in DNA databasing, forensic casework, archeological specimens, preimplantation and prenatal diagnoses [1-4]. The amelogenin gene is a single copy gene, homologues of which are located on Xp22.1-Xp22.3 and Yp 11.2 [5]. Regions on this gene that are sufficiently conserved are amplified for simultaneous detection of the X and Y alleles in gender identification procedures. Primers bind to the first intron region of the amelogenin gene on the X and Y-chromosomes [6] and amplify regions that differ in base sequence, hence resulting in products that are easily distinguishable by differences in size and sequence. The most widely used primer set [6] delimits a 6 bp deletion on the X-chromosome and produces fragments of 106 bp and 112 bp for the X and Y chromosomes respectively. Presence of two amplified products indicates a male genotype, while a single amplicon implies female genotype. However, mutations in the Y-derived fragment of the gene may result in amplification failure of the Y-allele, causing misidentification of the biological sample as of a female. Similarly, mutations on the X homologue would also result in non-amplification of the X-derived fragment although the genotype would still be identified as male due to amplification of the Y-amelogenin allele. Recently, a few studies have revealed misidentification of the male genotype while employing the amelogenin gender test [[7-9]]. Failures in accurate determination of gender have been reported to be particularly high among individuals of Indian origin. The frequency of failure was observed to be 8 % by Santos et al. [7], while Thangaraj et al. [9] reported 5 cases of amelogenin failure (1.85 %) among the 270 Indian males studied. The failure rate of the amelogenin sex test was particularly high (3.6 %) in an Indian population group from Malaysia [10]. However, a parallel study testing a larger number of individuals from the Austrian National DNA database reported a failure rate of 0.018 % [11]. The high frequency in incidence of failures in the Indian sub-continent prompted us to scrutinize the amelogenin typing results of 7,214 individuals (including 4,257 males) belonging to 104 different endogamous populations that were genotyped as part of our DNA databasing project. Individuals were sampled from diverse geographic regions across India such that all existing socio-ethnic groups and linguistic families were represented. In this paper, we report failures in genotyping of male individuals due to mutations originating in the Y-homologue of the amelogenin gene. We have further characterized the nature and extent of mutations and provide evidence for a plausible inherited mode of transmission of the mutation.

Methods

Population samples analyzed

DNA was isolated by standard organic extraction method [12] either from blood or buccal swabs of consenting 4,257 male and 2,957 female individuals belonging to 104 different endogamous groups. Individuals represented major caste and tribal groups of India, which were sampled from across 20 geographical regions of India (Table 1, Figure 1).
Table 1

Incidences in failures of gender testing among the 104 endogamous populations of India tested for amelogerin gene efficacy

S.NoStatePopulationSocial GroupIndividuals TestedFailure in Gender Analysis (No of samples)
1Jammu & kashmirBaltiTribe67Nil
DrokpaTribe38Nil
ArgonTribe51Nil
BuddhistReligious Group156Nil
2Himachal PradeshHPRajputCaste50Nil
3UttaranchalTharuTribe45Nil
JaunsariTribe45Nil
BhokshaTribe42Nil
4Uttar PradeshKanyakubj BrahminCaste98Nil
UP JatCaste48Nil
UP ThakurCaste48Nil
KhatriCaste471
UP KurmiCaste45Nil
5BiharBihar BrahminCaste59Nil
BhumiharCaste65Nil
RajputCaste58Nil
KayasthCaste53Nil
YadavCaste44Nil
KurmiCaste50Nil
BaniyaCaste45Nil
6GujaratGujarat PatelCaste45Nil
7MaharastraDesasth BrahminCaste701
Chitpavan BrahminCaste78Nil
MarathaCaste651
DhangarCaste150Nil
PawaraTribe82Nil
KatkariTribe95Nil
Madia GondTribe45Nil
Mahadeo KoliTribe45Nil
8ChattisgarhBrahminCaste51Nil
SatnamiCaste50Nil
TeliCaste50Nil
Dheria GondTribe35Nil
AghariaTribe701
OroanTribe42Nil
9JharkhandHoTribe50Nil
BhumijTribe56Nil
KhariaTribe83Nil
MundaTribe64Nil
BirhorTribe61Nil
SanthalTribe61Nil
OroanTribe60Nil
10WestbengalBrahminCaste110Nil
KayasthCaste103Nil
MahishyaCaste60Nil
NamasudraCaste55Nil
BauriCaste54Nil
MaheliTribe49Nil
KarmaliTribe51Nil
KoraTribe59Nil
LodhaTribe99Nil
11OrrisaOriya BrahminCaste57Nil
KaranCaste62Nil
KhandayatCaste621
GopeCaste60Nil
ParojaTribe781
Juang Tribe50Nil
SaoraTribe35Nil
12Andhra PradeshAndhra BrahminCaste106Nil
RajuCaste66Nil
Kappu NaiduCaste104Nil
Kamma ChaudharyCaste106Nil
ReddyCaste107Nil
KomatiCaste104Nil
YerukulaTribe101Nil
ChenchuTribe100Nil
Naikpod GondTribe104Nil
LambadiTribe107Nil
GollaCaste65Nil
SakunupaksholluCaste30Nil
13Tamil NaduChakkiliarCaste49Nil
Tanjore KallarCaste1011
VanniyarCaste871
PallarCaste33Nil
GounderCaste56Nil
IrularTribe54Nil
ParaiyarCaste21Nil
14KeralaNairCaste87Nil
15KarnatakaIyenger BrahminCaste651
LingayatCaste98Nil
GowdaCaste56Nil
BhoviCaste52Nil
ChristianReligious Group55Nil
MuslimReligious Group65Nil
KuruvaTribe601
16SikkimBhutiaTribe75Nil
NepaliCaste110Nil
LepchaTribe48Nil
17MizoramMaraTribe90Nil
HmarTribe80Nil
LaiTribe92Nil
LuseiTribe92Nil
KukiTribe105Nil
18Arunachal PradeshAdi PasiTribe203Nil
19ManipurGaroTribe110Nil
MeiteiTribe105Nil
NagaTribe106Nil
HmarTribe101Nil
Manipuri MuslimReligious Group101Nil
20Andaman & Nicobar IslandsGreat AndamaneseTribe24Nil
JarawaTribe50Nil
OngeTribe16Nil
NicobareseTribe28Nil
ShompenTribe33Nil

* NUMBER OF POPULATIONS ANALYZED: 104; 4257 MALES OUT OF 7214 INDIVIDUALS ANALYZED IN GENETIC PROFILING

Figure 1

Map depicting the regions covered in the study and location of samples where amelogenin deletion were observed.

Map depicting the regions covered in the study and location of samples where amelogenin deletion were observed. Incidences in failures of gender testing among the 104 endogamous populations of India tested for amelogerin gene efficacy * NUMBER OF POPULATIONS ANALYZED: 104; 4257 MALES OUT OF 7214 INDIVIDUALS ANALYZED IN GENETIC PROFILING

Amelogenin typing using commercial genotyping kits

The DNA samples were amplified using commercial multiplex short tandem repeat (STR) kits; PowerPlex® 16 system (Promega Corporation, Madison, USA) and Identifiler™ (Applied Biosystems, Foster City, CA), which include the amelogenin marker for gender determination. Genotyping of the amplified products was performed on an ABI Prism™ 377 DNA Sequencer (PE Applied Biosystems, Foster City, CA). The amelogenin profile was determined from the electropherograms by comparing the presence or absence of 106 and 112 bp peaks with known male and female controls. Females exhibit a single peak of 106 bp while males exhibit two peaks of 106 and 112 bps.

Amelogenin typing using newly designed primers and other published primers

Samples that showed abnormal amelogenin peak profiles with the commercial kits were reamplified with primers described by Steinlechner et al. [11] followed by genotyping as described above. Male samples exhibit two peaks of 219 and 225 bp, while female samples exhibit a single peak at 219 bp. Additional primers were designed for amplifying the region identified by Roffey et al. [8] to decipher the origin of mutations. The sequences of new primers designed to facilitate detection of mutation are as follows: 1. #P1: 5'- TTACGGCCATATTTAGGA-3' (for amplification of X and Y homologues) 2. #P2: 5'- GAAAGAGTCAATCCGAATGGT-3' (for amplification of Y homologue)

Analysis of SRY, Y-STRs and Y-SNPs

To confirm the gender of the studied samples, a sex-determining locus (SRY) [13] specific to males, was amplified. Occurrence of a single 93 bp amplicon would distinguish an authentic male DNA sample from a female DNA sample. Further, four Y- short tandem repeats (Y-STRs) [14,15] (DYS19, DYS389I, DYS389II and DYS390) were amplified to determine the extent of deletion of the Y-chromosome and to determine if Y-STR haplotype profiles were shared between individuals. Y-STR amplification was carried out in a single tube multiplex reaction [14] and genotyped on an ABI Prism™ 377 DNA Sequencer (PE Applied Biosystems, Foster City, CA). Y-single nucleotide polymorphisms (Y-SNPs) (M89, M9, M172, 92R7, M45, M20, M70, M214, M69, M124, M173, M17) [16] were profiled hierarchically to identify the lineage of the test samples.

Results and Discussion

Out of the 4,257 males analyzed with either PowerPlex® 16 or Identifiler™ multiplex system, 10 confirmed male samples exhibited a dropout of the 112 bp amelogenin Y-allele (Table 1). To verify the cause of observed abnormalities, we tested such samples with alternate primer pairs that encompassed the region amplified with primers reported by Sullivan et al. [6] and, are also typically used in the commercial kits. Amplification of the test samples with the primer set described by Steinlechner et al. [11] resulted in complete absence of the 225 bp Y-specific product. All 10 ambiguous samples were confirmed to be from male individuals on testing with male-specific SRY locus, which yielded the characteristic 93 bp amplicon reconfirming the gender of these subjects as males. Additional analysis with four Y-chromosomal STR markers, DYS19, DYS389I, DYS389II and DYS390, yielded complete and different Y-STR haplotype profiles. Amplification of Y-STR indicates that these samples had failed the amelogenin typing either due to mutation in the primer-binding region [17] or due to deletions in the amelogenin region (11.2p) on the Y-chromosome [11]. Among the 10 samples, eight distinct Y-STR haplotype profiles were observed; one was shared between Khatri and Kuruva and, another one by Agharia and Kallar (Table 2). Further amplification and sequencing was carried out using the forward primer of Steinlechner et al. [11] and a set of newly designed reverse primers spanning the hypothetical region of mutation – #P1, which is 62 bp downstream, and #P2, a Y-specific primer that is 43 bp downstream to the Steinlechner's reverse primer binding region, in order to determine the nature and extent of mutation. The newly designed primers depicted in Fig.2, result in 287 bp and 268 bp amplicon for #P1 and #P2 respectively, for the Y-chromosome, when used along with the forward primer of Steinlechner et al., #P1 results in a 281 bp product for the X-chromosome. However, the newly designed and validated primer sets also failed to amplify the Y-homologue in test samples suggesting deletion of a significant portion of the amelogenin region in male samples. The deletion in amelogenin gene has recently been mapped to span around 2.5 Mb [18].
Table 2

Y-chromosome profiles of the amelogenin-deletion individuals*

S. NoSampleY-SNPDYS 19DYS 389IDYS 389IIDYS 390
1KallarNA15122925
2VanniyarJ215132924
3AghariaNA15122925
4KhatriNA15133025
5Iyenger BrahminJ214132924
6KuruvaNA15133025
7KhandayatJ215113023
8ParojaJ215132625
9Desasth BrahminJ214133023
10MarathaJ215112825

NA: Samples not be examined for Y-SNPs

* Integers in bold represent shared haplotype between Kallar and Agahria; while those in bold italics represent haploype sharing between Khatri and Kuruva

Y-chromosome profiles of the amelogenin-deletion individuals* NA: Samples not be examined for Y-SNPs * Integers in bold represent shared haplotype between Kallar and Agahria; while those in bold italics represent haploype sharing between Khatri and Kuruva Y-chromosome nucleotide sequence of the human amelogenin gene (GenBank Accession Number M55419) showing the location of annealing regions of the primer sets used in this study. The overall rate of failure among the Indian population was found to be 0.23%. Table 1 shows the frequency of failure among different endogamous groups. Failures were exhibited by both caste groups (Khatri, Desasth Brahmin, Maratha, Khandayat, Tanjore Kallar, Vanniyar and Iyenger Brahmin) and tribal populations (Agharia, Paroja, and Kuruva) while Mongoloid and Negrito populations were not found to harbor the deletions (Fig. 1). Interestingly, we observed that these deletions were present predominantly in individuals belonging to the J2 Y-chromosomal lineage. J2 is found in approximately 5.1% of the Indian population, while majority of the Indian males harbor H (25%), R1a1 (19%) and R2 (16%) haplogroups in their Y-chromosomes [19]. Probably originating in the Middle East [20], the J2 lineage has been found distributed across southeastern Europe and Asia with frequencies of 6.5% in Central Asians [16], 23.8% in Sephardic Jews, 20% in Lebanese, 17.8% in Konyan Turks, 16.3% among Italians of Apulia, 13.6% in French Basque [20], 10.2% in Moroccan Arabs [21]. The above observations and positive amplification of the SRY gene and the appearance of discrete Y-STR haplotypes, suggests that the mutations probably arose independently on a J2 Y chromosome lineage background. Of the endogamous populations screened in this study, ~10 % exhibited failures in the amelogenin gender test. Since the extent of deletion is large to avoid amplification dropout of the Y-homologue with currently available commercial primer sets, we suggest it would be prudent to include an additional gender test such as SRY and/or Y-STR testing for accurate gender identification of biological specimens.

Conclusion

Earlier studies have reported high failure rates in amelogenin-based gender testing of individuals from the Indian sub-continent. In this study, we have analyzed 4,257 male samples and report a failure rate of 0.23%. Due to ease of typing, this test has gained wide acceptance and has been integrated into routine automated genetic profiling procedures. However, the fallibility of the amelogenin test raises concern over its continued use especially in medical and forensic sciences. Although our study indicates that individuals belonging to the J2 lineage are more prone to deletion in Y-derived amelogenin gene, further corroborating studies are desired. The amelogenin-based gender test thus needs to be applied with caution, with supplementation with other Y-chromosome specific analyses for reliable gender identification.

Competing interests

The author(s) declare that they have no competing interests.

Authors' contributions

VKK conceptualized the study and contributed significantly in data interpretation and manuscript preparation. SS and TS contributed equally towards designing and carrying out of experiments, data analyses and in manuscript preparation. RT provided critical and valuable information for data processing. All authors read and approved the final manuscript.

Pre-publication history

The pre-publication history for this paper can be accessed here:
  20 in total

1.  A prehistory of Indian Y chromosomes: evaluating demic diffusion scenarios.

Authors:  Sanghamitra Sahoo; Anamika Singh; G Himabindu; Jheelam Banerjee; T Sitalaximi; Sonali Gaikwad; R Trivedi; Phillip Endicott; Toomas Kivisild; Mait Metspalu; Richard Villems; V K Kashyap
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-13       Impact factor: 11.205

2.  Reliability of DNA-based sex tests.

Authors:  F R Santos; A Pandya; C Tyler-Smith
Journal:  Nat Genet       Date:  1998-02       Impact factor: 38.330

3.  Multiplex DNA typing of short-tandem-repeat loci on the Y chromosome.

Authors:  A J Redd; S L Clifford; M Stoneking
Journal:  Biol Chem       Date:  1997-08       Impact factor: 3.915

4.  Evaluation of Y-chromosomal STRs: a multicenter study.

Authors:  M Kayser; A Caglià; D Corach; N Fretwell; C Gehrig; G Graziosi; F Heidorn; S Herrmann; B Herzog; M Hidding; K Honda; M Jobling; M Krawczak; K Leim; S Meuser; E Meyer; W Oesterreich; A Pandya; W Parson; G Penacino; A Perez-Lezaun; A Piccinini; M Prinz; C Schmitt; L Roewer
Journal:  Int J Legal Med       Date:  1997       Impact factor: 2.686

5.  A large interstitial deletion encompassing the amelogenin gene on the short arm of the Y chromosome.

Authors:  Wanda Lattanzi; Marilena C Di Giacomo; Gennaro M Lenato; Guglielmina Chimienti; Gianfranco Voglino; Nicoletta Resta; Gabriella Pepe; Ginevra Guanti
Journal:  Hum Genet       Date:  2005-02-22       Impact factor: 4.132

6.  A rapid and quantitative DNA sex test: fluorescence-based PCR analysis of X-Y homologous gene amelogenin.

Authors:  K M Sullivan; A Mannucci; C P Kimpton; P Gill
Journal:  Biotechniques       Date:  1993-10       Impact factor: 1.993

7.  Simultaneous DNA 'fingerprinting', diagnosis of sex and single-gene defect status from single cells.

Authors:  I Findlay; A Urquhart; P Quirke; K Sullivan; A J Rutherford; R J Lilford
Journal:  Hum Reprod       Date:  1995-04       Impact factor: 6.918

8.  Sex identification of archaeological human remains based on amplification of the X and Y amelogenin alleles.

Authors:  M Faerman; D Filon; G Kahila; C L Greenblatt; P Smith; A Oppenheim
Journal:  Gene       Date:  1995-12-29       Impact factor: 3.688

9.  A gene from the human sex-determining region encodes a protein with homology to a conserved DNA-binding motif.

Authors:  A H Sinclair; P Berta; M S Palmer; J R Hawkins; B L Griffiths; M J Smith; J W Foster; A M Frischauf; R Lovell-Badge; P N Goodfellow
Journal:  Nature       Date:  1990-07-19       Impact factor: 49.962

View more
  21 in total

1.  Differential pattern of genetic variability at the DXYS156 locus on homologous regions of X and Y chromosomes in Indian population and its forensic implications.

Authors:  Sanjukta Mukerjee; Meeta Mukherjee; Tania Ghosh; D Kalpana; Anil Kumar Sharma
Journal:  Int J Legal Med       Date:  2011-11-25       Impact factor: 2.686

2.  Y chromosome interstitial deletion induced Y-STR allele dropout in AMELY-negative individuals.

Authors:  Yan Ma; Jin-Zhi Kuang; Ji Zhang; Gui-Min Wang; Yu-Jian Wang; Wei-Min Jin; Yi-Ping Hou
Journal:  Int J Legal Med       Date:  2012-06-06       Impact factor: 2.686

3.  Molecular characterization of a polymorphic 3-Mb deletion at chromosome Yp11.2 containing the AMELY locus in Singapore and Malaysia populations.

Authors:  Rita Y Y Yong; Linda S H Gan; Yuet Meng Chang; Eric P H Yap
Journal:  Hum Genet       Date:  2007-06-23       Impact factor: 4.132

4.  Amelogenin sex determination by pyrosequencing of short PCR products.

Authors:  Frank Tschentscher; Ulrich H Frey; Thomas Bajanowski
Journal:  Int J Legal Med       Date:  2008-03-20       Impact factor: 2.686

5.  "GenderPlex" a PCR multiplex for reliable gender determination of degraded human DNA samples and complex gender constellations.

Authors:  Anna Esteve Codina; Harald Niederstätter; Walther Parson
Journal:  Int J Legal Med       Date:  2008-12-17       Impact factor: 2.686

6.  Distinct breakpoints in two cases with deletion in the Yp11.2 region in Japanese population.

Authors:  Reiko Kumagai; Yoshitoshi Sasaki; Takuya Tokuta; Hitoshi Biwasaka; Aya Matsusue; Yasuhiro Aoki; Koji Dewa
Journal:  Hum Genet       Date:  2010-02-03       Impact factor: 4.132

7.  Sex determination.

Authors:  Eleanor A M Graham
Journal:  Forensic Sci Med Pathol       Date:  2006-12       Impact factor: 2.007

8.  A novel method of male sex identification of human ancient skeletal remains.

Authors:  María Teresa Navarro-Romero; María de Lourdes Muñoz; Enrique Alcala-Castañeda; Eladio Terreros-Espinosa; Eduardo Domínguez-de-la-Cruz; Normand García-Hernández; Miguel Ángel Moreno-Galeana
Journal:  Chromosome Res       Date:  2020-07-03       Impact factor: 5.239

9.  Remarkably little variation in proteins encoded by the Y chromosome's single-copy genes, implying effective purifying selection.

Authors:  Steve Rozen; Janet D Marszalek; Raaji K Alagappan; Helen Skaletsky; David C Page
Journal:  Am J Hum Genet       Date:  2009-12       Impact factor: 11.025

10.  Evolution and survival on eutherian sex chromosomes.

Authors:  Melissa A Wilson; Kateryna D Makova
Journal:  PLoS Genet       Date:  2009-07-17       Impact factor: 5.917

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.